Coronavirus

Stanford creates virtual scientist to accelerate drug and vaccine discovery

Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.

Why AI-powered video analytics holds the key to enforcing social distancing

Andrew Eggington, Finance Director, Ipsotek, explores the many ways in which artificial intelligence (AI) can be used to enforce social distancing and better protect society.

Improving urban transport and mobility in a post-pandemic city

Taylor Anderton, Actuary and Data Scientist at Capgemini, discusses why smart cities are key to improving urban transport and mobility in a post-pandemic world.

Single-cell genomics: Clinical strategies for COVID-19

Here, Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group argues that single-cell genomics empowers clinical strategies for COVID-19.

Social value: How can the construction sector deliver a more tangible impact?

Bev Hurley CBE, Chair of the Institute of Economic Development, ponders how construction spend can address the significant inequalities facing disadvantaged and left-behind communities.

What can the Leicester garment sector fallout teach us about supply chain risks?

Gavin Proudley, Global Director, Due Diligence and Managed Services at Dow Jones Risk & Compliance, discusses supply chain risks and the Leicester garment sector.

Downgraded exam results in Scotland cause anger

Exam results released in Scotland create waves of anger after a mass downgrading of teacher-assessed grades, likely to be similar for England in late August.

How COVID-19 is driving AI adoption across the healthcare industry

Vincent Grasso, Global Healthcare & Life Sciences Lead, IPsoft, discusses how COVID-19 is driving AI adoption across the healthcare industry.

How technology can support social distancing

In this article, we explore how crowd simulation technology can help businesses to plan effective social distancing.

Why COVID-19 is a concern for people with diabetes

Prof. Andrew Boulton, MD, DSc (Hon), FACP, FICP, FRCP, President of the International Diabetes Federation, highlights why COVID-19 is a particular concern for people living with diabetes.

Brexit impact: Health and brain research

Prof Monica Di Luca, President, European Brain Council, sheds light on the greater impact of Brexit in terms of health and brain research being up for negotiation.

Medical school curriculum must include health technology

Dr Ravi Tomar discusses why the medical school curriculum must include health technology.

The role of technology in ophthalmology

Mr Romesh Angunawela, Founding Partner, Ophthalmic Consultants of London, enlightens us on the role of technology in ophthalmology as part of the NHS’s efforts to tackle the COVID backlog.

COVID-19 higher among minority and socioeconomically disadvantaged children

A new study led by Children's National Hospital researchers shows that minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection.

How COVID-19 will reshape supply chains across the economy

Philip Ashton, CEO of 7bridges, discusses how COVID-19 will reshape supply chains across the economy.

Heart disease: The collateral damage of COVID-19

Professor Lina Badimon and Elisabetta Zanon from the European Society of Cardiology provide their thoughts on understanding and addressing the impact of COVID-19 on heart disease.

Let’s get better prepared for the next health crisis in the EU!

Paul De Raeve, Secretary General and Elisabeth Adams, President of the European Federation of Nurses Associations state the case for being better prepared for the next health crisis in the European Union in light of COVID-19.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders